A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database
Congenital Anomalies · 2024
DOI: 10.1111/cga.12579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Congenital Anomalies, 2024. Verfasst von Yuichi Uwai und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Aichi Gakuin University, Nagoya, Japan. Hauptthemen laut MEDLINE: Valproic Acid, Pharmacovigilance, Strabismus, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
This pharmacovigilance study investigated the relationship between antiepileptic drugs and congenital strabismus, utilizing the FDA Adverse Event Report System database between 2014 and 2023. Out of 28 347 889 reports of adverse events in 10 937 764 cases, we identified 1104 reports of strabismus and 67 of congenital strabismus. Valproic acid was the most frequently implicated primary suspect drug (95 and 14 cases, respectively). Ninety‐five reports involved transplacental valproic acid exposure, yielding an information component (IC) of 7.06 (IC‐2 × standard deviation: 5.50). A multivariate analysis showed that transplacental exposure to valproic acid correlated with strabismus (adjusted odds ratio: 8.47, 95% CI: 6.74–10.65). We revealed a robust safety signal linking valproic acid to congenital strabismus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Aichi Gakuin University, Nagoya, Japan.
ORCID-Profile: Yuichi Uwai
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Uwai, Y., & Nabekura, T. (2024). A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database. Congenital Anomalies. https://doi.org/10.1111/cga.12579
Vancouver
Uwai Y, Nabekura T. A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database. Congenital Anomalies. 2024. doi:10.1111/cga.12579
BibTeX
@article{Uwai2024,
author = {Uwai, Yuichi and Nabekura, Tomohiro},
title = {A safety signal for congenital strabismus associated with valproic acid: A pharmacovigilance analysis utilizing the FDA Adverse Event Reporting System database},
journal = {Congenital Anomalies},
year = {2024},
doi = {10.1111/cga.12579}
}
EUVIMED